Tag: Codexis

Welcome to the Protein Revolution: The Digest’s 2017 Multi-Slide Guide to Codexis

Welcome to the Protein Revolution: The Digest’s 2017 Multi-Slide Guide to Codexis

December 1, 2017 |

Codexis is a leading protein engineering company that applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. Codexis CEO John Nicols gave this illuminating presentation on the company’s progress, […]

Read More

The Protein Engineers: The Digest’s 2017 Multi-Slide Guide to Codexis

September 30, 2017 |

Codexis is a leading protein engineering company that applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. This illuminating presentation looks at the company’s progress promise, and most recent […]

Read More

Codexis’s cash flows turn positive ahead of schedule

Codexis’s cash flows turn positive ahead of schedule

August 11, 2014 |

In California, Codexis will be delivering a positive cash flow in 2014 according to recently released financial results for its second quarter. Revenues for the quarter ended June 30, 2014 were $6.6 million, a 6% decrease from $7.0 million of revenues recorded in the second quarter of 2013. According to President and CEO John Nicols, “After delivering results in line […]

Read More

Codexis inks multi-$M GSK deal

Codexis inks multi-$M GSK deal

July 15, 2014 |

In California, Codexis announced the signing of a platform technology license agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Codexis granted GSK a license to use Codexis’ proprietary CodeEvolver® protein engineering platform technology in the field of human healthcare. The license allows GSK to use Codexis’ platform technology to develop novel enzymes for […]

Read More

From the Salad Days of Sugar to the Golden Days of Gas

From the Salad Days of Sugar to the Golden Days of Gas

December 11, 2013 |

Traveling through the seasons with Calysta Energy chairman and CEO Alan Shaw, from the summer of IPOs with Codexis — and now back into springtime, courtesy of a technology that plays cheap natural gas. For eight o’clock in the morning on the last day of a long BIO Pac Rim conference, Alan Shaw was looking […]

Read More

Codexis receives notice of patent breach from Dyadic

Codexis receives notice of patent breach from Dyadic

August 6, 2013 |

In California, Codexis announced that the company has received notice from Dyadic International, Inc. alleging that Codexis is in breach under a license agreement established by the companies on November 14, 2008. According to the notice, Dyadic intends to terminate the agreement in 60 days if the breach is not cured to Dyadic’s satisfaction. Codexis […]

Read More

Chemtex and Codexis announce milestone reaching in developing detergent alchohols technology

Chemtex and Codexis announce milestone reaching in developing detergent alchohols technology

June 18, 2013 |

In Italy, Chemtex and Codexis announced the successful scale-up in the production of CodeXol detergent alcohols using cellulosic sugars. The scale-up was achieved at a 1,500 liter demonstration facility at Chemtex’s R&D complex in Tortona, Italy and is a key milestone in the ongoing effort initiated by the two companies to develop a fully integrated […]

Read More

CO2 Solutions and Codexis extend JDA through March 2015

CO2 Solutions and Codexis extend JDA through March 2015

May 23, 2013 |

In Canada, CO2 Solutions announced that it has renewed until March 31, 2015 its Joint Development Agreement with Codexis to continue the development and deployment of CO2 Solutions’ enzymatic carbon capture technology. Under the amended and restated JDA, CO2 Solutions’ proprietary enzymatic method for the efficient capture of carbon dioxide from large emission sources will continue to benefit from Codexis’ […]

Read More

Codexis lowers losses to $9.6 million for Q1 2013

Codexis lowers losses to $9.6 million for Q1 2013

May 9, 2013 |

In California, Codexis reports revenues for the first quarter of 2013 were $11.5 million, a 45% increase from $7.9 million in the fourth quarter of 2012. Net operating costs were $21.1 million, a nearly 11% decrease from the fourth quarter of 2012. The net loss was $9.6 million, or a loss of $0.25 per share, […]

Read More

Shaw turns back on cellulosic and dives into natgas

Shaw turns back on cellulosic and dives into natgas

May 1, 2013 |

In California, former CEO of Codexis and current CEO of Calysta Energy Alan Shaw now says that it’s not economical to produce next generation fuels from crops, so has switched to natural gas as feedstock. He says that falling gas prices thanks to shale gas to funneling funds that had been going to biofuel technology […]

Read More